Key points are not available for this paper at this time.
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action.
Cockburn et al. (Mon,) studied this question.